Literature DB >> 10650106

Infantile fibromatosis in childhood: findings on MR imaging and pathologic correlation.

J M Ahn1, H K Yoon, Y L Suh, E Y Kim, B K Han, J H Yoon, S H Kim, J M Cho, S M Kim, H S Kang.   

Abstract

AIM: The objective of this study was to analyse the MR imaging findings of infantile fibromatosis of childhood and to correlate them with histopathological features.
MATERIALS AND METHODS: Seven patients with histologically proven infantile fibromatosis were included in this study. The findings on MR images were retrospectively evaluated and then correlated with the pathological features. Findings on MR imaging evaluated included signal intensity, extent of hyperintense area on T2-weighted images, margins of the lesion, the degree and pattern of enhancement and the presence of fatty tissue. Pathological features evaluated included cellularity, collagenization, and myxoid change. A five point scale was used for the evaluation of the extent of hyperintense area on MR imaging, and each of pathological features.
RESULTS: On T1-weighted images, the lesions were iso-intense in two patients; iso- and hypointense in three; and iso-, hypo- and hyperintense in two. On T2-weighted images, iso-, hypo- and hyperintense areas were mixed in all patients, the hyperintense area being the largest portion of the lesion. The margins of the lesions were infiltrative in four patients (57%), smooth in two (29%) and mixed in one (14%). Enhancement was marked in five patients (72%) and diffuse in five (71%). Regardless of the hyperintense signal intensity on T2-weighted images, the grades of each pathologic feature were variable.
CONCLUSION: Infantile fibromatosis on MR imaging causes an enhancing mass, that is largely hyperintense on T2-weighted images. Areas of high signal intensity on T2-weighted images corresponded to variable grades of cellularity, collagenization, or myxoid change. Copyright 2000 The Royal College of Radiologists.

Entities:  

Mesh:

Year:  2000        PMID: 10650106     DOI: 10.1053/crad.1999.0321

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  8 in total

Review 1.  MR imaging of soft tissue tumors and tumor-like lesions.

Authors:  Tal Laor
Journal:  Pediatr Radiol       Date:  2003-12-12

2.  Lipofibromatosis: magnetic resonance imaging features and pathological correlation in three cases.

Authors:  Daniela Vogel; Alberto Righi; Jennifer Kreshak; Angelo Paolo Dei Tos; Biagio Merlino; Eugenio Brunocilla; Daniel Vanel
Journal:  Skeletal Radiol       Date:  2014-02-08       Impact factor: 2.199

3.  Aggressive fibromatosis of head and neck in a child.

Authors:  Atul Gupta; Satish Nair; Ajith Nilakantan; Amit Sood
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-13

4.  Clinical and imaging findings of systemic hyalinosis: two cases presenting with congenital arthrogryposis.

Authors:  So-Young Yoo; Ji Hye Kim; Ho Seok Kang; Yong Seung Hwang; Ki Joong Kim; In-One Kim; Jung-Eun Cheon; Su-Mi Shin; Chong Jai Kim; Jee Hun Lee; Mun Hyang Lee; Jong Hee Chae
Journal:  Skeletal Radiol       Date:  2010-02-06       Impact factor: 2.199

5.  Myofibromatosis: imaging characteristics.

Authors:  Khaldoun Koujok; Robert E Ruiz; Ramiro J Hernandez
Journal:  Pediatr Radiol       Date:  2004-11-19

6.  Lipofibromatosis: report of a rare paediatric soft tissue tumour.

Authors:  A N Deepti; Vrisha Madhuri; Noel Malcolm Walter; Rekha Aley Cherian
Journal:  Skeletal Radiol       Date:  2008-06       Impact factor: 2.199

7.  Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics.

Authors:  Jung Hyo Rhim; Ji-Hoon Kim; Kyung Chul Moon; Sun-Won Park; Chul-Ho Sohn; Seung Hong Choi; Tae Jin Yun; Kee-Hyun Chang
Journal:  Neuroradiology       Date:  2013-01-22       Impact factor: 2.804

8.  A large infiltrating fibrous hamartoma of infancy in the abdominal wall with rare associated tuberous sclerosis.

Authors:  Hye-Jeong Han; Gye-Yeon Lim; Chang-Young You
Journal:  Pediatr Radiol       Date:  2009-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.